“Great things in business are never done by one person; they’re done by a team of people.” — Steve Jobs
That spirit is behind Bynd Bio, founded by Christopher Veale, a platform built to help CRO teams move proposals faster with less friction. For Day 19 of the Propel Earth Founder Showcase, we’re highlighting a founder focused on speed and clarity for contract labs.
The administrative drag in drug discovery is a known problem. Christopher, a biomedical engineer who went deep into cloud SaaS, built a practical solution that meets CROs where they work. At Propel Earth, our role is simple: connect this ready to deploy platform with forward thinking CROs who will benefit from it right away.
Why This Matters
In drug discovery, time is not just money—it is lives. Bynd Bio turns messy call notes into a structured study configuration, generates an accurate quote using the lab’s own pricing, assembles SOW text, and tracks client comments in one flow. That reduces the back and forth that keeps science stuck in spreadsheets and accelerates decision making.
Key Facts & Traction
Product Ready: AI assisted platform for study configuration, quote generation with your pricing, SOW assembly, and comment resolution in a single workflow.
Targeted Go to Market: Focused on pilot partners to produce measurable, data rich case studies.
Engaging the Market: In active discussions with multiple labs, including an enterprise account, signaling clear demand.
Mission & Impact
Bynd Bio’s mission is to make buying complex scientific services fast and simple for contract labs. The impact: shorter proposal cycles, cleaner scopes, and more time for scientists to do the work that moves programs forward.
The Opportunity
If you lead a CRO or CDMO and want proposals that move faster with fewer rounds of edits, this is worth a look. Early partners can compress proposal timelines, delight clients, and demonstrate agility where it counts.
Connect with Christopher Veale and want more info view his Featured Founder profile here:
lnkd.in/efTk85PD
